Iron overload in children undergoing cancer treatments

Pediatric Blood and Cancer

Volumn 60, Issue 12, 2013, Pages 1982-1987

  De Ville de Goyet, Maëlle ^a,b   Moniotte, Stéphane ^a,b   Robert, Annie ^b   Dupont, Sophie ^a   Vermylen, Christiane ^a   Veyckemans, Francis ^b   Brichard, Bénédicte ^a,b  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Blood transfusion; Childhood cancer; Heart disease; Iron overload; Liver disease; Long term effects

Indexed keywords

FERRITIN;

ADOLESCENT; ARTICLE; CANCER THERAPY; CARDIOVASCULAR MAGNETIC RESONANCE; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; ERYTHROCYTE VOLUME; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; HUMAN; INFANT; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD;

BLOOD TRANSFUSION; CHILDHOOD CANCER; HEART DISEASE; IRON OVERLOAD; LIVER DISEASE; LONG-TERM EFFECTS;

ADOLESCENT; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; FEMALE; FERRITINS; HUMANS; INFANT; IRON OVERLOAD; MALE; NEOPLASMS; PROSPECTIVE STUDIES;

EID: 84885778064     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24705     Document Type: Article

References (39)

1. Kohgo Y, Ikuta K, Ohtake T, et al. Body iron metabolism and pathophysiology of iron overload. Int J Hematol 2008; 88:7-15.
2. Vermylen C. What is new in iron overload? Eur J Pediatr 2008; 167:377-381.
3. Taher AT, Mussalam KM, Inati A. Iron overload: Consequences, assessment, and monitoring.
4. Kaltasser JP, Werner E. Diagnosis and clinical evaluation of iron overload. Baillieres Clin Haematol 1989; 2:363-389.
5. Sirlin CB, Reeder SB. Magnetic resonance imaging quantification of Liver Iron. Magn Reson Imaging Clin N Am 2010; 18:359-381.
6. Anderson LJ. Assessment of iron overload with T2* magnetic resonance imaging. Prog Cardiovasc Dis 2011; 54:287-294.
7. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001; 22:2171-2179.
8. Carpenter JP, He T, Kirk P. et al. On T2* magnetic resonance and cardiac iron. Circulation 2011; 123:1519-1528.
9. Tziomalos K, Perifanis V. Liver iron content determination by magnetic resonance imaging. World J Gastroenterol 2010; 16:1587-1597.
10. St Pierre TG, Clark PR, Chua-anusorn W, et al. Non-invasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005; 105:855-861.
11. Wood JC, Enriquez C, Nilesh G, et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005; 106:1460-1465.
12. Mulrooney DA, Yeazel MW, Kawashima T, et al. Cardiac outcomes in a cohort of adult survivors of childhood, adolescent cancer: A report from the childhood cancer survivor study. Br Med J 2009; 339:b4606.
13. Armstrong GT, Liu Q, Yasui Y, et al. Late mortality among 5-year survivors of childhood cancer: A summary from the childhood cancer survivor study. J Clin Oncol 2009; 27:2328-2338.
14. Lipshultz SE, Alvarez JA, Scully RE. Anthracycline associated cardiotoxicity in survivors of childhood cancer. Heart 2008; 94:525-533.
15. de Ville de Goyet M, Moniotte S, Brichard B. Cardiotoxicity of childhood cancer treatment: Update and current knowledge on long-term follow-up. Pediatr Hematol Oncol 2012; 29:395-414.
16. Shankar SM, Marina N, Hudson MM, et al. Monitoring for cardiovascular disease in survivors of childhood cancer: Report from the cardiovascular disease task force of the children's oncology group. Pediatrics 2008; 121:387-396.
17. Mulder RL, van Dalen EC, Van den Hof M, et al. Hepatic late adverse effects after antineoplastic treatment for childhood cancer. Cochrane Database Syst Rev 2011; Art. No.:CD008205.
18. Mulder RL, Kremer LCM, Koot BGP, et al. Surveillance of hepatic late adverse effects in a large cohort of long-term survivors of childhood cancer: Prevalence and risk factors. Eur J Cancer 2013; 49:185-193.
19. Vag T, Kentouche K, Krumbein I, et al. Non-invasive measurement of liver iron concentration at MRI in children with acute leukaemia: Initial results. Pediatr Radiol 2011; 41:980-984.
20. Reddy K, Eng J, Carlson C, et al. Impact of transfusional support for childhood cancer-Peering behind the curtain. Pediatr Blood Cancer 2011; 56:908 (abstract).
21. Kazak AE, Hocking MC, Ittenbach RF, et al. A revision of the intensity of treatment rating scale: Classifying the intensity of pediatric cancer treatment. Pediatr Blood Cancer 2012; 59:96-99.
22. Lorenz CH, Walker ES, Morgan VL, et al. Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. J Cardiovasc Magn Reson 1999; 1:7-21.
23. Buechel EV, Kaiser T, Jackson C, et al. Normal right- and left ventricular volumes and myocardial mass in children measured by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2009; 11:19.
24. Ruccione KS, Mudambi K, Sposto R, et al. Association of projected transfusional iron burden with treatment intensity in childhood cancer survivors. Pediatr Blood Cancer 2012; 59:697-702.
25. Eng J, Fish JD. Insidious iron burden in pediatric patients with acute lymphoblastic leukemia. Pediatr Blood Cancer 2011; 56:368-371.
26. McDonald GB, Tirumali N. Intestinal and liver toxicity of antineoplastic drugs. West J Med 1984; 140:250-259.
27. Castellino S, Muir A, Shah A, et al. Hepato-biliary late effects in survivors of childhood and adolescent cancer: A report from the Children's Oncology Group. Pediatr Blood Cancer 2010; 54:663-669.
28. McKay PJ, Murphy JA, Cameron S, et al. Iron overload and liver dysfunction after allogenic or autologous bone marrow transplantation. Bone Marrow Transplant 1996; 17:63-66.
29. Chotsampancharoen T, Gan K, Kasow KA, et al. Iron overload in survivors of childhood leukemia after allogeneic hematopoietic stem cell transplantation. Pediatr Transplant 2009; 13:348-352.
30. Halonene P, Mattila J, Ruuska B, et al. Liver histology after intensified therapy for childhood acute lymphoblastic leukemia: Microvesicular fatty change and siderosis are the main findings. Med Pediatr Oncol 2003; 40:148-154.
31. Halonen P, Mattila J, Suominen P, et al. Iron overload in children who are treated for acute lymphoblastic leukemia estimated by liver siderosis and serum iron parameters. Pediatrics 2003; 111:91-96.
32. Noetzli LJ, Papudesi J, Coates TD, et al. Pancreatic iron loading predicts cardiac iron loading in thalassemia major. Blood 2009; 114:4021-4026.
33. Lee DH. Jacobs DR, Jr. Serum markers of stored body iron are not appropriate markers of health effects of iron: A focus on serum ferritin. Med Hypotheses 2004; 62:442-445.
34. Pakbaz Z, Fischer R, Fung E, et al. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients. Pediatr Blood Cancer 2007; 49:329-332.
35. Adamkiewicz TV, Abboud MR, Paley C, et al. Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury. Blood 2009; 114:4632-4638.
36. Szoke D, Panteghini M. Diagnostic value of transferrin. Clin Chim Acta 2012; 413:1184-1189.
37. Au WY, Lam WM, Chu WC, et al. A magnetic resonance imaging study of iron overload in hematopoietic stem cell transplant recipients with increased ferritin levels. Transplant Proc 2007; 39:3369-3374.
38. Leung AW, Chu WC, Lam WW, et al. Magnetic resonance imaging assessment of cardiac and liver iron load in transfusion dependent patients. Pediatr Blood Cancer 2009; 53:1054-1059.
39. Schulz KF, Altman DG, Moher D. for the consort group. CONSORT. Statement: Updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340:c332.